Castleman Disease with MDM2/CDK4 Protein Expression: a Potential Mimic of Inflammatory Variant of Liposarcoma with Significant Consequences

被引:1
|
作者
Georgantzoglou, Natalia [1 ]
Baker, Michael [1 ,2 ]
Liu, Xiaoying [1 ,2 ]
Kerr, Darcy A. [1 ,2 ]
Linos, Konstantinos [1 ,2 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA
[2] Geisel Sch Med Dartmouth, Hanover, NH USA
关键词
Castleman disease; well-differentiated liposarcoma; dedifferentiated liposarcoma; inflammatory liposarcoma; retroperitoneum; DENDRITIC CELL-SARCOMA; WELL-DIFFERENTIATED LIPOSARCOMA; MDM2; ABNORMALITIES; TUMOR;
D O I
10.1177/10668969221080083
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Castleman disease is a rare benign lymphoproliferative disorder that includes a spectrum of distinct histopathological entities. The differential diagnosis of Castleman disease is broad and includes lymphomas, HIV-related lymphadenopathy, autoimmune disorders, and inflammatory liposarcoma. When Castleman disease occurs in the retroperitoneum, the distinction from the inflammatory variant of well-differentiated liposarcoma can be very challenging in small biopsies. Herein we report a case of Castleman disease that presented as a retroperitoneal mass and expressed MDM2 and CDK4 by immunohistochemistry. To our knowledge, this is the first report of Castleman disease staining positively for MDM2/CDK4, and it underscores how immunohistochemistry can potentially serve as a pitfall when differentiating this rare entity from retroperitoneal sarcomas.
引用
收藏
页码:753 / 759
页数:7
相关论文
共 50 条
  • [41] Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor A case report
    Hou, Tien-Chi
    Wu, Pao-Shu
    Huang, Wen-Yu
    Yang, Yi-Ting
    Kien Thiam Tan
    Liu, Shih-Hua
    Chen, Yu-Jen
    Chen, Shu-Jen
    Su, Ying-Wen
    MEDICINE, 2020, 99 (12)
  • [42] Dedifferentiated Liposarcoma With Meningothelial-like Whorls, Metaplastic Bone Formation, and CDK4, MDM2, and p16 Expression: A Morphologic and Immunohistochemical Study
    Thway, Khin
    Robertson, David
    Thway, Yi
    Fisher, Cyril
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (03) : 356 - 363
  • [43] Co-amplification of CDK4 and MDM2 plus HMGA2 fusion in a patient with myogenic differentiation dedifferentiated liposarcoma.
    Huang, Gang
    Li, Xianan
    Wang, Chunyang
    He, Qifan
    Wang, Xiaojuan
    CANCER RESEARCH, 2021, 81 (13)
  • [44] Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours
    Aleixo, P. B.
    Hartmann, A. A.
    Menezes, I. C.
    Meurer, R. T.
    Oliveira, A. M.
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (12) : 1127 - 1135
  • [45] Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours
    Tos, APD
    Doglioni, C
    Piccinin, S
    Sciot, R
    Furlanetto, A
    Boiocchi, M
    Dal Cin, P
    Maestro, R
    Fletcher, CDM
    Tallini, G
    JOURNAL OF PATHOLOGY, 2000, 190 (05): : 531 - 536
  • [46] MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition
    Kovatcheva, Marta
    Liu, David D.
    Dickson, Mark A.
    Klein, Mary E.
    O'Connor, Rachael
    Wilder, Fatima O.
    Socci, Nicholas D.
    Tap, William D.
    Schwartz, Gary K.
    Singer, Samuel
    Crago, Aimee M.
    Koff, Andrew
    ONCOTARGET, 2015, 6 (10) : 8226 - 8243
  • [47] CDK4 inhibition diminishes p53 activation by MDM2 antagonists
    Sriraman, Anusha
    Dickmanns, Antje
    Najafova, Zeynab
    Johnsen, Steven A.
    Dobbelstein, Matthias
    CELL DEATH & DISEASE, 2018, 9
  • [48] Diagnostic Utility and Limitations of Immunohistochemistry of p16, CDK4, and MDM2 and Automated Dual-color In Situ Hybridization of MDM2 for the Diagnosis of Challenging Cases of Dedifferentiated Liposarcoma
    Kobayashi, Anna
    Sakuma, Toshiko
    Fujimoto, Masayo
    Jimbo, Naoe
    Hirose, Takanori
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (10) : 758 - 763
  • [49] MDM2, CDK4 and EGFR1 in intimal sarcomas of pulmonary artery
    Centeno Haro, M.
    Ortega Salas, R.
    Sanchez Sanchez, R.
    Medina Perez, M.
    VIRCHOWS ARCHIV, 2015, 467 : S111 - S111
  • [50] Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification
    Lyle, Pamela L.
    Bridge, Julia A.
    Simpson, Jean F.
    Cates, Justin M.
    Sanders, Melinda E.
    HISTOPATHOLOGY, 2016, 68 (07) : 1040 - 1045